Oxygenators Market

Oxygenators Market Size and Share:

The global oxygenator market size was valued at USD 271.9 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 419.52 Million by 2033, exhibiting a CAGR of 4.94% from 2025-2033. North America currently dominates the market, holding a market share of over 45.3% in 2024. The market is driven by the high prevalence of cardiovascular and respiratory diseases, increasing surgical procedures, and strong healthcare infrastructure advancements in the region.

The global oxygenator market is driven by the growing prevalence of cardiovascular and respiratory diseases worldwide. According to the World Health Organization (WHO), the mortality risk for cardiovascular disease (CVDs), cancer, diabetes, or chronic respiratory disease between the ages of 30 and 70 is 18%. This has increased the demand for oxygenators in critical care and surgeries, aiding the market growth. Moreover, ongoing advancements in medical technology have improved oxygenator efficiency and safety, boosting adoption rates, and fueling the market demand. Besides this, the rising geriatric populations are contributing to the market expansion, as chronic health conditions require oxygenation support. Also, the increasing number of surgical procedures, especially open-heart surgeries is impelling the market growth. Furthermore, the expanding healthcare infrastructure in emerging economies enhances access to advanced medical devices, catalyzing the market growth.

The United States oxygenator market holds a market share of 83.20%. The demand in the region is driven by a high prevalence of cardiovascular and pulmonary diseases. In line with this, the aging population contributes significantly, as elderly individuals are more susceptible to chronic conditions requiring oxygenation support. Also, the country's well-developed healthcare system ensures widespread access to cutting-edge technologies, fostering the market growth. Concurrently, the increased numbers of cardiac surgeries and extracorporeal membrane oxygenation (ECMO) procedures, are providing an impetus to the market. Apart from this, continuous technological advancements in oxygenators enhance efficiency and safety, boosting adoption and propelling the market forward.

Oxygenators Market Trends:

Growing Prevalence of Heart Disease

Heart disease cases represent the main cause of the increased demand for oxygenators throughout the globe. Research published by the British Heart Foundation in January 2024 has found that some 640 million people suffering from heart and circulatory diseases reside in Asia alone. With a steadily increased number of patients, patients will demand the application of oxygenation technology and enhanced cardiac surgery devices. The oxygenators market is expected to grow massively with continued global attention being focused on improving cardiac care. With the increase in the incidence of heart diseasebi, along with advances in medical technologies, there's a demand for innovative solutions in surgeries that require the oxygenation process, resulting in overall growth in this market.

Rising Geriatric Population

The number of people aged 65 and older will more than double, from 761 million in 2021 to 1.6 billion by 2050, and the population aged 80 and above is likely to grow even faster. According to the United Nations, demographic shifts indicate that age-related conditions such as cardiovascular and respiratory disorders are increasing at a very high rate, most of which demand advanced oxygenation solutions. Hence, the increased demand for healthcare is pushing oxygenators into critical care areas and increasing the markets for oxygenators. With the aging population, healthcare systems are destined to face several challenges. Thus, oxygenators are likely to see a rise in demand shortly as the elderly are treated and cared for better.

Strategic Innovations and Integrated Systems

Market players are making strategic innovations to keep up with the growing demand from consumers, especially through improving systems that integrate oxygenators. One of the key releases in this line is the LivaNova Essenz Perfusion System which hit the market in April 2024. It is designed for both adults and pediatric open-heart surgery patients, combining several main elements to make surgical efficiency and safety more achievable. The system integrates advanced membrane oxygenators and other critical elements, which have become a hallmark of the industry's shift toward comprehensive cardiac care solutions. While improving procedural outcomes, innovations are also significantly contributing to the growth of the global oxygenators market by establishing new benchmarks in medical device sophistication and functionality.

Oxygenators Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global oxygenator market, along with forecasts at the global, regional, and country levels from 2025-2033. The market has been categorized based on type, age group, and application.

Analysis by Type:

• Membrane Oxygenator
• Bubble Oxygenator

Membrane oxygenators dominate the oxygenator segment because of their high performance and versatility in various clinical settings and operations. The growth of this segment is further attributed to the growing incidence of cardiovascular and respiratory diseases which necessitate extracorporeal oxygenation support. Additionally, the development of new membranes has enhanced the efficiency of the gas exchange and increased the durability and biocompatibility of the membrane, which is increasing the uptake of the equipment. High incidences of cardiac and pulmonary procedures such as open heart procedures are major drivers of increased demand. Another factor is the increasing population of geriatric patients who are more susceptible to chronic diseases and thus require oxygenators. Moreover, the growing use of extracorporeal membrane oxygenation or ECMO therapy in the critical care segment contributes to the segment’s visibility. Furthermore, pressures towards patient safety and clinical outcomes have made people prefer membrane oxygenators to bubble oxygenators, to ensure they gain more market standards.

Analysis by Age Group:

• Neonates
• Pediatric
• Adults

The neonate segment in the oxygenator market is driven by the increasing prevalence of congenital heart defects and respiratory complications in newborns. Specialized oxygenators designed for delicate physiology ensure precise gas exchange and temperature control, essential for neonatal care. Growing neonatal intensive care units (NICUs) and advancements in pediatric cardiac surgery further bolster demand for neonatal oxygenators, driving the market forward.

The pediatric segment is growing due to increasing incidences of congenital heart diseases and respiratory diseases among children. Pediatric oxygenators are designed to suit the sizes and metabolic requirements of children. Moreover, ongoing technological enhancements in pediatric surgical procedures and ECMO therapies along with rising awareness of early management of chronic ailments are providing an impetus to the market.

The adult segment dominates due to the high incidence of cardiovascular diseases, respiratory failures, and surgeries requiring oxygenation support. Aging populations and lifestyle-related conditions like obesity and smoking increase demand. Advanced oxygenator technologies enhance safety and efficiency in adult surgeries while expanding critical care and ECMO usage for severe respiratory conditions further fueling the market growth.

Analysis by Application:

• Respiratory
• Cardiac
• Extracorporeal Cardiopulmonary
• Resuscitation (ECPR)

Respiratory leads the market with a share of 59.3%. This segment dominates the oxygenator market, driven by the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and pneumonia. In addition, the rising pollution levels and smoking rates exacerbate respiratory health issues, boosting the demand for oxygenators. The segment also benefits from the growing adoption of ECMO therapy for severe respiratory failure. Moreover, continuous advancements in oxygenator technology, including improved biocompatibility and gas exchange efficiency, enhance their suitability for long-term respiratory support. Concurrently, the aging population is more prone to chronic respiratory conditions, which is another critical growth factor. Apart from this, the expanding healthcare infrastructure and critical care capabilities in emerging markets are boosting the adoption of oxygenators in respiratory care and increasing awareness of advanced respiratory therapies.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America dominates the oxygenator market with a share of 45.3%. The demand in this segment is driven by advanced healthcare infrastructure and the high prevalence of cardiovascular and respiratory diseases. The aging population of the region is significantly contributing to the market growth, as elderly individuals are more prone to conditions requiring oxygenation support. Moreover, the increasing adoption of ECMO therapy in critical care settings further fuels demand. The region also benefits from robust R&D activities, leading to continuous advancements in oxygenator technologies that enhance efficiency, safety, and biocompatibility. The high volume of surgical procedures, particularly cardiac and pulmonary surgeries, boosts the utilization of oxygenators. Besides this, favorable reimbursement policies and increasing healthcare expenditure support widespread adoption, thereby impelling the market growth.

Key Regional Takeaways:
 

United States Oxygenators Market Analysis

The rising prevalence of chronic obstructive pulmonary disease, which is the third leading cause of death in the U.S. aside from cancer and heart conditions, is one of the biggest factors in oxygenators uptake. The American Lung Association says that 11 million people are diagnosed with COPD in the country yearly, thus the more urgent need for respiratory-based health care. This trend is expected to increase the demand for membrane oxygenators, which are widely used in ECMO devices to provide life support to patients with severe cardiopulmonary diseases. Membrane oxygenators are advanced over the traditional bubble oxygenators. They offer features such as better platelet functioning, higher platelet count, and reduced hemolysis during perfusion. These features enhance patient outcomes while making them more attractive in critical care. Demand for advanced respiratory support devices is on the rise which will expand the use of membrane oxygenators and augment the growth of the market for oxygenators in the U.S.

Europe Oxygenators Market Analysis

The significant burden of circulatory system diseases on healthcare systems and government budgets will drive the Europe oxygenators market. According to an industrial report, there were 1.71 million deaths in the EU because of diseases in the circulatory system in 2021, representing 32.4% of all deaths. That trend is expected to be maintained, thus boosting the demand for oxygenators to treat patients with disorders of the circulatory system. Such higher prevalence in the region's areas of coronary artery disease, heart failure, and pulmonary embolism will contribute more to market growth. It is the increasing adoption of minimally invasive surgical procedures and the incidence of respiratory disease that adds to demand and growth. European healthcare is shifting toward the oxygenation of advanced therapy methods to further improve the chances of improved patient outcomes through reduced cost of healthcare and other preventive measures. As a result, the Europe oxygenators market is expected to see remarkable growth, with the prominent players investing in research and development to innovate and further improve oxygenator technology. This trend is likely to continue as the demand for effective and efficient oxygenation therapies increases.

Asia Pacific Oxygenators Market Analysis

The significant burden of circulatory system diseases on healthcare systems and government budgets will drive the Asia Pacific oxygenators market. India forms a fifth of the total deaths due to coronary heart disease worldwide, and deaths due to CHD are up by 100% since 1990, as per industrial reports. It is estimated to further increase by 50% by 2030. In addition, the contribution of the region in curbing major diseases, such as that of South Korea donating USD 4 million to Indonesia in 2021, further fuels the market for oxygenators. The increasing adoption of minimally invasive surgical procedures and the rising incidence of respiratory diseases will also drive demand. As the Asian healthcare sector shifts towards advanced oxygenation therapies to improve patient outcomes and reduce healthcare costs, the demand for effective and efficient oxygenation therapies is expected to increase. The Asia Pacific oxygenators market is expected to witness remarkable growth as the key players in the market invest in research and development for innovation and improvement in oxygenator technology.

Latin America Oxygenators Market Analysis

The burden of chronic respiratory diseases in Latin America will drive the Latin America oxygenators market. Chronic obstructive pulmonary disease (COPD) and tuberculosis are leading causes of morbidity and mortality in Brazil. In addition, smoking is a key factor in the growth of the respiratory devices market; 9.1% of the population aged 15+ years smokes daily, according to OECD statistics for 2021. Significant tobacco use will increase the risk of developing respiratory diseases such as asthma and COPD. Growth in the increasing rates of tuberculosis in Brazil according to the WHO Global Tuberculosis Report, dated 2022, further fuels the market. The incidence of tuberculosis in Brazil stood at 48 per 100,000 people in 2021. In turn, a high prevalence of smoking and tuberculosis is expected to propel the Latin America oxygenators market across the forecast period, wherein the demand for effective and efficient oxygenation therapies rises to enhance patient outcomes as well as reduce healthcare costs.

Middle East and Africa Oxygenators Market Analysis

The Middle East and Africa oxygenators market will be propelled by the high incidence burden of asthma in this region. For instance, asthma has a severe burden in countries like Uganda with mortality 90 times greater than that found in the United Kingdom. A study by the Journal of the Pan African Thoracic Society (JPATS) showed that only 33% of asthma patients in Uganda had the disease in control, pointing out the lack of awareness about monitoring and the severity of the disease. The adoption of cost-effective solutions such as pulse oximeters for respiratory monitoring will spur the growth of the market. As the healthcare sector in the region shifts toward advancing technologies to improve patient outcomes and reduce healthcare costs, the demand for effective and efficient oxygenation therapies is expected to increase. Additionally, the rising prevalence of respiratory diseases and increased awareness of asthma management will also drive demand for oxygenators in the Middle East and Africa.

Competitive Landscape:

The competitive landscape of the oxygenator market is characterized by intense innovation and strategic activities among key players. Companies are heavily investing in research and development (R&D) to enhance oxygenator efficiency, biocompatibility, and safety. Mergers, acquisitions, and collaborations are common strategies to expand product portfolios and market presence. Major trends include the integration of advanced materials and the development of portable and lightweight oxygenators for improved usability. Moreover, regulatory approvals for novel products further drive competition. Also, the increasing focus on ECMO systems and personalized solutions tailored to patient needs is shaping market dynamics. Additionally, partnerships with healthcare providers and institutions strengthen distribution networks, enhancing players' competitive edge.

The report provides a comprehensive analysis of the competitive landscape in the oxygenator market with detailed profiles of all major companies, including:

• Braile Biomédica
• Chalice Medical Ltd
• Eurosets S.r.l.
• Getinge AB
• Livanova Plc
• Medtronic plc
• MicroPort
• Nipro Corporation
• Senko Medical Instrument Mfg. Co. Ltd.
• Terumo Medical Corporation (Terumo Corporation)
• Xenios AG (Fresenius Medical Care AG & Co. KGaA)

Latest News and Developments:

• October 2024: Chalice Medical, Inc. announced that Maimonides Medical Center in Brooklyn, New York, was among the first hospitals in the United States to deploy the state-of-the-art CMO8 oxygenator.
• September 2024: Inspira Technologies OXY B.H.N. Ltd. was awarded a U.S. Patent for its patented VORTX orbiting blood oxygenation delivery system. VORTX can oxygenate blood without requiring fiber membranes, thus being able to revolutionize medicine by offering the possibility of minimizing damage to blood with all costs associated with such damage.
• April 2023: Abbott achieved two FDA clearances related to the CentriMag Life Support System. Its blood pump can be utilized for an extended period among adults under Extracorporeal Membrane Oxygenation (ECMO).

Oxygenators Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the oxygenator market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global oxygenator market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the oxygenator industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.